A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2
CONCLUSIONS: 33 of 100 SLE patients immunized with BNT162b2 vaccine against SARS-CoV-2, presented SLE flares (47 episodes in total); 5 of these patients required in-hospital management and all fully recovered; 26 patients had SARS-CoV-2 infection; three required hospitalization, one died.PMID:38237938 | DOI:10.1177/09612033241227811
Source: Lupus - Category: Rheumatology Authors: Ernesto Zavala-Flores Jannin Salcedo-Matienzo Roberto Huamanchumo-Guzman Alfredo Berrocal-Kasay Graciela S Alarc ón Source Type: research
More News: Hospital Management | Hydroxychloroquine | Lupus | Pfizer | Rheumatology | SARS | Study | Vaccines